Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

HYEXHEALTHY EXTRACTS INC.

OTC · CIK 0001630176
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2833 Medicinal Chemicals & Botanical Products
FY end1231
XBRL facts224

Identity from submissions API

NameHEALTHY EXTRACTS INC.
CIK0001630176
TickersHYEX
ExchangesOTC
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2833 Medicinal Chemicals & Botanical Products
EIN472594704
LEI—
Fiscal year end1231
State of incorporationNV NV
Phone702-505-0471
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • HEALTHLY EXTRACTS INC. (2021-03-11T05:00:00.000Z → 2021-03-11T05:00:00.000Z)
  • GREY CLOAK TECH INC. (2015-01-12T05:00:00.000Z → 2021-02-19T05:00:00.000Z)
Business address
7375 COMMERCIAL WAY
SUITE 125
HENDERSON
NV
89011
NV
Mailing address
7375 COMMERCIAL WAY
SUITE 125
HENDERSON
NV
89011
NV

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

No Financialist filing articles yet for this CIK.

SEC filings

197 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-17 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,3.02,9.01 0001096906-26-001792 000-55572 261563279 34 872831 1 1
2026-11-16 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-26-001782 000-55572 261561836 34 5681187 1 1
2026-09-18 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 5.02 0001096906-26-001377 000-55572 261388886 34 118987 1 1
2026-08-14 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-26-001237 000-55572 261283914 34 5205619 1 1
2026-07-24 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,3.02,9.01 0001096906-26-001117 000-55572 261198022 34 479579 1 1
2026-07-13 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 5.02 0001096906-26-001087 000-55572 261171950 34 119495 1 1
2026-07-06 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 5.02 0001096906-26-001054 000-55572 261155766 34 118995 1 1
2026-05-18 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,2.01,3.02,5.02,9.01 0001096906-26-000819 000-55572 26992680 34 580046 1 1
2026-05-14 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-26-000791 000-55572 26976179 34 4560049 1 1
2026-04-09 10-K HEALTHY EXTRACTS INC. - FORM 10-K SEC FILING 0001096906-26-000515 000-55572 26849326 34 6873996 1 1
2026-04-01 NT 10-K HEALTHY EXTRACTS INC. 12B-25 0001096906-26-000452 000-55572 26823941 34 19392
2025-11-14 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-25-001864 000-55572 251487380 34 4960562 1 1
2025-10-02 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,1.02,2.01,3.02,5.01,5.02,9.01 0001096906-25-001627 000-55572 251368174 34 401712 1 1
2025-09-23 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 5.02 0001096906-25-001557 000-55572 251332378 34 126035 1 1
2025-08-22 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001096906-25-001421 005-89602 251246580 34 6384
2025-08-22 4 PRIMARY DOCUMENT 0001096906-25-001408 4928
2025-08-22 3 PRIMARY DOCUMENT 0001096906-25-001407 3915
2025-08-13 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-25-001303 000-55572 251212839 34 4986233 1 1
2025-07-24 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,2.01,3.02,5.01,5.02,9.01 0001096906-25-001186 000-55572 251147770 34 327841 1 1
2025-05-13 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-25-000753 000-55572 25938548 34 5001626 1 1
2025-04-22 10-K/A HEALTHY EXTRACTS INC. - FORM 10-K SEC FILING 0001096906-25-000553 000-55572 25854666 34 6035193 1 1
2025-04-01 10-K HEALTHY EXTRACTS INC. - FORM 10-K SEC FILING 0001096906-25-000370 000-55572 25798834 34 6027587 1 1
2025-04-01 NT 10-K HEALTHY EXTRACTS INC. 12B-25 0001096906-25-000368 000-55572 25798694 34 20696
2024-11-12 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-24-002090 000-55572 241446343 34 4901215 1 1
2024-08-14 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-24-001703 000-55572 241205681 34 4908268 1 1
2024-05-20 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-24-001186 000-55572 24962011 34 4782314 1 1
2024-05-15 NT 10-Q HEALTHY EXTRACTS INC. NT10Q 0001096906-24-001131 000-55572 24948384 34 20746
2024-05-10 RW HEALTHY EXTRACTS INC. FORM RW 0001096906-24-001092 333-269676 24934959 NE 6865
2024-05-10 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,4.01,9.01 0001096906-24-001090 000-55572 24934858 34 261987 1 1
2024-04-24 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.02,9.01 0001096906-24-000919 000-55572 24870464 34 128869 1 1
2024-04-01 10-K HEALTHY EXTRACTS INC. - FORM 10-K SEC FILING 0001096906-24-000706 000-55572 24810696 34 6148143 1 1
2023-12-29 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 5.03,9.01 0001096906-23-002463 000-55572 231523597 34 143803 1 1
2023-11-22 S-1/A HEALTHY EXTRACTS INC. - FORM S-1/A SEC FILING 0001096906-23-002270 333-269676 231433789 33 10057986 1 1
2023-11-14 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-23-002196 000-55572 231408045 34 4835994 1 1
2023-11-08 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,9.01 0001096906-23-002103 000-55572 231385352 34 153573 1 1
2023-10-24 S-1/A HEALTHY EXTRACTS INC. - FORM S-1/A SEC FILING 0001096906-23-002041 333-269676 231342274 33 9407434 1 1
2023-10-06 S-1/A HEALTHY EXTRACTS INC. - FORM S-1/A SEC FILING 0001096906-23-001908 333-269676 231313769 33 9398033 1 1
2023-09-14 S-1/A HEALTHY EXTRACTS INC. - FORM S-1/A SEC FILING 0001096906-23-001780 333-269676 231254665 33 9687170 1 1
2023-09-07 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,9.01 0001096906-23-001758 000-55572 231241931 34 171244 1 1
2023-09-05 DEF 14C HEALTHY EXTRACTS DEF-14C 0001096906-23-001749 000-55572 231236101 34 95402
2023-08-28 S-1/A HEALTHY EXTRACTS INC. - FORM S-1/A SEC FILING 0001096906-23-001697 333-269676 231209865 33 9753829 1 1
2023-08-24 PRE 14C HEALTHY EXTRACTS PRE 14C 0001096906-23-001685 000-55572 231202304 34 95520
2023-08-14 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-23-001602 000-55572 231171869 34 4776975 1 1
2023-08-04 S-1/A HEALTHY EXTRACTS INC. - FORM S-1/A SEC FILING 0001096906-23-001498 333-269676 231141693 33 8599160 1 1
2023-07-17 4 PRIMARY DOCUMENT 0001096906-23-001420 4831
2023-06-12 S-1/A HEALTHY EXTRACTS INC. - FORM S-1/A SEC FILING 0001096906-23-001294 333-269676 231007495 33 7253006 1 1
2023-05-15 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-23-001093 000-55572 23924327 34 3273780 1 1
2023-04-11 S-1/A HEALTHY EXTRACTS INC. - FORM S-1/A SEC FILING 0001096906-23-000775 333-269676 23813862 33 5636454 1 1
2023-03-31 10-K HEALTHY EXTRACTS, INC. - FORM 10-K SEC FILING 0001096906-23-000699 000-55572 23786972 34 4818601 1 1
2023-03-23 8-K HEALTHY EXTRACTS, INC. - FORM 8-K SEC FILING 1.01,3.02,9.01 0001096906-23-000630 000-55572 23754156 34 202998 1 1
2023-02-10 S-1 HEALTHY EXTRACTS, INC. - FORM S-1 SEC FILING 0001096906-23-000313 333-269676 23608302 33 19169942 1 1
2023-01-27 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,3.02,9.01 0001096906-23-000221 000-55572 23562979 34 629886 1 1
2023-01-20 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,9.01 0001096906-23-000150 000-55572 23541080 34 468693 1 1
2022-11-08 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-22-002672 000-55572 221369972 34 2773887 1 1
2022-10-28 DEF 14C HEALTHY EXTRACTS DEF 14C 0001096906-22-002581 000-55572 221341216 34 90361
2022-10-17 PRE 14C HEALTHY EXTRACTS PRE 14C 0001096906-22-002509 000-55572 221314064 34 91008
2022-10-12 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,9.01 0001096906-22-002474 000-55572 221306874 34 1081086 1 1
2022-08-16 3 PRIMARY DOCUMENT 0001096906-22-001926 3776
2022-08-16 4 PRIMARY DOCUMENT 0001096906-22-001925 7405
2022-08-15 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-22-001904 000-55572 221166463 34 2664301 1 1
2022-07-08 4 PRIMARY DOCUMENT 0001096906-22-001583 10677
2022-07-05 3 PRIMARY DOCUMENT 0001096906-22-001557 6457
2022-06-29 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,9.01 0001096906-22-001521 000-55572 221055393 34 120627 1 1
2022-06-07 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 1.01,3.02,5.02,9.01 0001096906-22-001343 000-55572 221000609 34 360993 1 1
2022-05-16 10-Q HEALTHY EXTRACTS INC. - FORM 10-Q SEC FILING 0001096906-22-001150 000-55572 22929848 34 2680371 1 1
2022-05-04 8-K HEALTHY EXTRACTS INC. - FORM 8-K SEC FILING 7.01,9.01 0001096906-22-001029 000-55572 22890700 34 3041937 1 1
2022-04-01 10-K 10-K 0001520138-22-000131 000-55572 22794972 34 4561332 1 1
2022-04-01 NT 10-K NT 10-K 0001520138-22-000129 000-55572 22794968 34 21087
2022-03-02 8-K CURRENT REPORT 1.01,3.02,9.01 0001520138-22-000087 000-55572 22703254 34 283651 1 1
2022-01-07 DEF 14C DEF 14C 0001520138-22-000005 000-55572 22517603 34 124575
2021-12-23 PRE 14C PRE 14C 0001520138-21-000811 000-55572 211517032 34 124767
2021-11-15 10-Q 10-Q 0001520138-21-000728 000-55572 211412197 34 3546044 1 1
2021-09-10 QUALIF xslQUALIFX01/primary_doc.xml 9999999994-21-000281 024-11481 211248438 33 1932
2021-09-08 CORRESP filename1.htm 0001520138-21-000527 8618
2021-09-03 10-Q/A 10-Q/A 0001520138-21-000523 000-55572 211237522 34 2991826 1 1
2021-09-03 1-A/A xsl1-A_X01/primary_doc.xml 0001520138-21-000519 024-11481 211235117 33 1040790
2021-08-25 1-A/A xsl1-A_X01/primary_doc.xml 0001520138-21-000482 024-11481 211203194 33 1047910
2021-08-16 10-Q FORM 10- FOR PERIOD ENDING JUNE 30, 2021 0001520138-21-000444 000-55572 211180032 34 2982367 1 1
2021-08-13 1-A/A xsl1-A_X01/primary_doc.xml 0001520138-21-000432 024-11481 211173416 33 959999
2021-08-06 1-A/A xsl1-A_X01/primary_doc.xml 0001520138-21-000396 024-11481 211152497 33 1036713
2021-08-03 10-K/A 10-K 0001520138-21-000388 000-55572 211140562 34 3754073 1
2021-08-03 10-Q/A 10-Q 0001520138-21-000386 000-55572 211140478 34 1790257 1
2021-07-29 8-K 8-K 7.01,9.01 0001520138-21-000361 000-55572 211125000 34 942287
2021-07-26 UPLOAD filename1.pdf 0000000000-21-009162 43913
2021-07-09 1-A/A xsl1-A_X01/primary_doc.xml 0001520138-21-000343 024-11481 211083041 33 1048405
2021-06-24 UPLOAD filename1.pdf 0000000000-21-007814 51152
2021-06-07 1-A/A xsl1-A_X01/primary_doc.xml 0001520138-21-000314 024-11481 21998499 33 1073282
2021-05-27 D xslFormDX01/primary_doc.xml 06b 0001520138-21-000298 021-400891 21971099 33 9848
2021-05-20 UPLOAD filename1.pdf 0000000000-21-006407 48083
2021-05-14 10-Q 10-Q 0001520138-21-000263 000-55572 21925945 34 1778163 1
2021-05-07 1-A/A xsl1-A_X01/primary_doc.xml 0001520138-21-000241 024-11481 21901764 33 2748625
2021-04-07 UPLOAD filename1.pdf 0000000000-21-004177 59897
2021-03-19 8-K 8-K 1.01,3.02,9.01 0001520138-21-000165 000-55572 21758640 34 312056
2021-03-11 1-A xsl1-A_X01/primary_doc.xml 0001520138-21-000150 024-11481 21732438 33 589224
2021-02-19 10-K 10-K 0001520138-21-000113 000-55572 21657371 34 3658158 1
2021-02-12 8-K 8-K CURRENT REPORT 1.01,3.02 0001520138-21-000099 000-55572 21625567 34 25446
2020-10-29 10-Q 10-Q 0001520138-20-000516 000-55572 201273122 34 1869874 1
2020-10-19 8-K 8-K 1.01,3.02 0001520138-20-000494 000-55572 201246098 34 25173
2020-10-05 DEF 14C DEF 14C 0001520138-20-000470 000-55572 201223417 34 411866
2020-10-01 S-8 S-8 0001520138-20-000464 333-249234 201217237 33 367771
2020-09-22 PRE 14C PRE 14C 0001520138-20-000445 000-55572 201188115 34 411791
2020-09-15 10-Q 10-Q 0001520138-20-000428 000-55572 201175725 34 1921116 1
2020-08-14 10-Q 10-Q 0001520138-20-000385 000-55572 201106811 34 1827671 1
2020-08-10 10-K 10-K 0001520138-20-000365 000-55572 201088940 34 2380399 1
2020-06-01 10-Q FORM 10-Q FOR PERIOD ENDING SEPT 30, 2019 0001520138-20-000252 000-55572 20931592 34 1851670 1
2020-05-29 10-Q QUARTERLY REPORT 0001520138-20-000248 000-55572 20926911 34 1815770 1
2020-05-28 10-Q FORM 10-Q FOR PERIOD ENDING MARCH 31, 2020 0001520138-20-000241 000-55572 20918873 34 2020360 1
2020-04-17 8-K FORM 8-K 1.01,3.02 0001520138-20-000175 000-55572 20798384 34 26392
2020-04-08 8-K FORM 8-K 1.01,3.02,9.01 0001520138-20-000155 000-55572 20781990 34 173109
2020-04-07 8-K 8-K 4.01 0001520138-20-000144 000-55572 20779023 34 51503
2020-04-01 10-K FORM 10-K FOR PERIOD ENDING DECEMBER 31, 2018 0001520138-20-000130 000-55572 20763566 34 2677424 1
2019-10-04 8-K CURRENT REPORT 1.01,3.02 0001520138-19-000371 000-55572 191138254 34 25454
2019-09-27 8-K 8K 5.02 0001520138-19-000338 000-55572 191121652 34 18787
2019-08-27 8-K CURRENT REPORT 1.01,3.02 0001520138-19-000316 000-55572 191054871 34 27332
2019-04-25 10-Q FORM 10-Q FOR PERIOD ENDING SEPTEMBER 30, 2018 0001520138-19-000107 000-55572 19768397 34 1981854 1
2019-02-22 3 PRIMARY DOCUMENT 0001394550-19-000004 2895
2019-02-08 8-K CURRENT REPORT 1.01,2.04,3.02,3.03,5.01,5.02,9.01 0001520138-19-000019 000-55572 19578990 34 43687
2018-12-06 4 OWNERSHIP DOCUMENT 0001520138-18-000339 7480
2018-11-14 NT 10-Q NT 10-Q 0001520138-18-000326 000-55572 181183030 34 21050
2018-10-29 8-K CURRENT REPORT 4.01,9.01 0001520138-18-000302 000-55572 181143638 34 46343
2018-10-22 4 OWNERSHIP DOCUMENT 0001520138-18-000297 7340
2018-10-22 3 OWNERSHIP DOCUMENT 0001520138-18-000296 4735
2018-10-04 8-K CURRENT REPORT 1.01,5.02 0001520138-18-000262 000-55572 181108537 34 26255
2018-09-26 SC 13G SCHEDULE 13G 0001078782-18-001064 005-89602 181087565 34 48169
2018-09-21 8-K CURRENT REPORT 5.02 0001520138-18-000245 000-55572 181080463 34 19811
2018-09-11 10-Q FORM 10-Q FOR PERIOD ENDED JUNE 30, 2018 0001520138-18-000232 000-55572 181064653 34 1668189 1
2018-08-14 NT 10-Q NT 10-Q 0001520138-18-000195 000-55572 181017812 34 20922
2018-07-13 10-Q/A FORM 10-Q FOR PERIOD ENDED MARCH 31, 2018 0001520138-18-000153 000-55572 18951618 34 1499136 1
2018-07-12 10-Q FORM 10-Q FOR PERIOD ENDED MARCH 31, 2018 0001520138-18-000147 000-55572 18951226 34 269394
2018-06-08 10-K FORM 10-K FOR PERIOD ENDED DECEMBER 31, 2017 0001520138-18-000125 000-55572 18888751 34 3163698 1
2018-04-04 UPLOAD filename1.pdf 0000000000-18-010098 35223
2018-04-02 NT 10-K NT 10-K 0001520138-18-000051 000-55572 18728637 34 22033
2018-03-29 8-K CURRENT REPORT 5.07 0001520138-18-000044 000-55572 18722068 34 33377
2018-02-28 DEF 14A DEF 14A 0001520138-18-000028 000-55572 18650188 34 137855
2018-02-16 CORRESP filename1.htm 0001520138-18-000023 14964
2018-02-06 PRE 14A PRE 14A 0001520138-18-000010 000-55572 18578528 34 138392
2018-01-04 8-K CURRENT REPORT 5.03,5.07,9.01 0001520138-18-000004 000-55572 18510558 34 37801
2017-12-29 8-K CURRENT REPORT 1.01,3.02 0001520138-17-000385 000-55572 171281760 34 22474
2017-11-20 8-K CURRENT REPORT 1.01,3.02,8.01 0001520138-17-000372 000-55572 171214472 34 34601
2017-11-15 10-Q FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2017 0001520138-17-000369 000-55572 171205798 34 1290666 1
2017-11-15 DEF 14A DEF 14A 0001520138-17-000367 000-55572 171205222 34 73303
2017-11-15 NT 10-Q NT 10-Q 0001520138-17-000364 000-55572 171204733 34 21905
2017-11-03 PRE 14A PRE 14A 0001520138-17-000343 000-55572 171177378 34 71535
2017-10-24 3 PRIMARY DOCUMENT 0001720666-17-000001 4389
2017-10-23 4 OWNERSHIP DOCUMENT 0001520138-17-000331 5610
2017-10-23 4 OWNERSHIP DOCUMENT 0001520138-17-000330 10406
2017-10-23 8-K CURRENT REPORT 1.01,3.02,5.02,5.03,9.01 0001520138-17-000329 000-55572 171149545 34 96372
2017-10-04 8-K CURRENT REPORT 8.01,9.01 0001520138-17-000317 000-55572 171122471 34 27895
2017-09-29 SC 13G SC 13G 0001144204-17-050678 005-89602 171111503 34 59704
2017-08-18 10-Q FORM 10-Q FOR THE PERIOD ENDED JUNE 30, 2017 0001520138-17-000282 000-55572 171041664 34 1282313 1
2017-08-14 NT 10-Q NT 10-Q 0001520138-17-000275 000-55572 171031431 34 21441
2017-05-25 4 OWNERSHIP DOCUMENT 0001520138-17-000228 8755
2017-05-25 SC 13D SC13D 0001520138-17-000227 005-89602 17869303 34 32534
2017-05-25 8-K CURRENT REPORT 1.01,3.02,5.02,9.01 0001520138-17-000226 000-55572 17869295 34 99092
2017-05-25 10-Q FORM 10-Q FOR PERIOD ENDED MARCH 31, 2017 0001520138-17-000225 000-55572 17869244 34 1566021 1
2017-05-15 NT 10-Q NT 10-Q 0001520138-17-000192 000-55572 17845934 34 21066
2017-05-01 SC 13D SC 13D 0001520138-17-000158 005-89602 17797603 34 86905
2017-04-28 4 OWNERSHIP DOCUMENT 0001520138-17-000155 12536
2017-04-28 3 OWNERSHIP DOCUMENT 0001520138-17-000154 2870
2017-04-17 10-K FORM 10-K FOR PERIOD ENDED DECEMBER 31, 2016 0001520138-17-000143 000-55572 17765427 34 11681720 1
2017-04-06 8-K CURRENT REPORT 1.01,3.02,5.02,5.03,9.01 0001520138-17-000132 000-55572 17746579 34 88980
2017-03-31 NT 10-K NT 10-K 0001520138-17-000118 000-55572 17727357 34 25333
2017-02-27 8-K CURRENT REPORT 5.03,5.07,9.01 0001520138-17-000076 000-55572 17642422 34 39175
2017-02-02 UPLOAD filename1.pdf 0000000000-17-003717 35955
2017-02-01 DEF 14A DEF 14A 0001520138-17-000032 000-55572 17563964 34 100867
2017-01-23 PRE 14A PRE 14A 0001520138-17-000026 000-55572 17539673 34 100506
2017-01-12 UPLOAD filename1.pdf 0000000000-17-001311 134369
2017-01-04 CORRESP filename1.htm 0001520138-17-000002 66260
2017-01-03 UPLOAD filename1.pdf 0000000000-17-000036 41766
2016-12-23 PRE 14C PRE 14C 0001520138-16-001320 000-55572 162069171 34 103293
2016-11-22 10-Q FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2016 0001520138-16-001265 000-55572 162011587 34 2031934 1
2016-11-14 NT 10-Q NOTIFICATION OF LATE FILING 0001520138-16-001238 000-55572 161996047 34 19609
2016-08-19 SC 13G SC 13G 0001520138-16-001105 005-89602 161843790 34 44156
2016-08-10 10-Q FORM 10-Q FOR PERIOD ENDED JUNE 30, 2016 0001520138-16-001081 000-55572 161819619 34 991319 1
2016-07-20 4 OWNERSHIP DOCUMENT 0001520138-16-001058 4472
2016-06-10 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001520138-16-000975,2016-06-10 9999999995-16-004874 333-202542 161709801 33 1743
2016-06-01 POS AM POST EFFECTIVE AMENDMENT NO. 1 0001520138-16-000975 333-202542 161688606 33 2056054 1
2016-05-16 10-Q FORM 10-Q FOR PERIOD ENDED MARCH 31, 2016 0001520138-16-000920 000-55572 161652469 34 943065 1
2016-03-30 10-K FORM 10-K FOR PERIOD ENDED DECEMBER 31, 2015 0001520138-16-000803 000-55572 161541007 34 5992924 1
2016-01-25 3 OWNERSHIP DOCUMENT 0001520138-16-000684 3548
2016-01-20 3 OWNERSHIP DOCUMENT 0001520138-16-000682 6102
2016-01-19 3 OWNERSHIP DOCUMENT 0001520138-16-000680 3474
2016-01-19 8-A12G FORM 8-A12G 0001520138-16-000678 000-55572 161347227 34 18618
2015-12-11 8-K CURRENT REPORT 1.01,5.02,9.01 0001520138-15-000527 333-202542 151284017 34 214778
2015-11-16 10-Q FORM 10-Q FOR PERIOD ENDED SEPTEMBER 30, 2015 0001520138-15-000477 333-202542 151233777 34 796228 1
2015-10-20 424B3 424B3 0001520138-15-000425 333-202542 151166033 33 751625
2015-07-22 10-Q 10-Q FOR PERIOD ENDED JUNE 30, 2015 0001520138-15-000326 333-202542 151000548 34 796568 1
2015-07-10 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2015-07-10 10:00:00 9999999995-15-001884 333-202542 15984651 33 1729
2015-07-07 CORRESP filename1.htm 0001520138-15-000309 5743
2015-06-19 S-1/A FORM S-1 AMENDMENT NO. 3 0001520138-15-000305 333-202542 15943150 33 926756
2015-06-16 UPLOAD filename1.pdf 0000000000-15-031907 143996
2015-06-03 S-1/A FORM S-1 AMENDMENT NO. 1 0001520138-15-000274 333-202542 15910956 33 727613
2015-05-27 UPLOAD filename1.pdf 0000000000-15-028217 175620
2015-05-12 S-1/A FORM S-1 AMENDMENT NO. 1 0001520138-15-000209 333-202542 15852483 33 648557
2015-04-02 UPLOAD filename1.pdf 0000000000-15-019344 187378
2015-03-06 S-1 FORM S-1 REGISTRATION STATEMENT 0001520138-15-000082 333-202542 15678967 33 1356016
2015-01-12 D xslFormDX01/primary_doc.xml 06b 0001214659-15-000264 021-231930 15521395 33 5502

Latest XBRL company facts

One latest value per concept from companyfacts (224 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 15.04M 2026-11-16 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
dei EntityPublicFloat Entity Public Float USD 4.08M 2025-06-30 2025 FY 10-K 2026-04-09 0001096906-26-000515
us-gaap AccountsAndNotesReceivableNet Accounts and Financing Receivable, after Allowance for Credit Loss USD 79,295 2018-12-31 2019 FY 10-K 2020-08-10 0001520138-20-000365
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 6,111 2016-12-31 2017 FY 10-K 2018-06-08 0001520138-18-000125
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 752,068 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 15,000 2018-12-31 2019 FY 10-K 2020-08-10 0001520138-20-000365
us-gaap AccountsReceivableNetCurrent Accounts Receivable, after Allowance for Credit Loss, Current USD 424,270 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap AccruedInvestmentIncomeReceivable Accrued Investment Income Receivable USD 4,762 2018-12-31 2019 FY 10-K 2020-08-10 0001520138-20-000365
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 573,662 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap AccruedPayrollTaxesCurrent Accrued Payroll Taxes, Current USD 7,188 2018-06-30 2018 Q2 10-Q 2018-09-11 0001520138-18-000232
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 23,153 2024-09-30 2024 Q3 10-Q 2024-11-12 0001096906-24-002090
us-gaap AcquisitionCostsCumulative Acquisition Costs, Cumulative USD 0 2023-12-31 2023 FY 10-K 2024-04-01 0001096906-24-000706
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 46.78M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap AdjustmentOfWarrantsGrantedForServices Adjustment of Warrants Granted for Services USD 15,379 2017-01-01 2017-12-31 2017 FY 10-K 2018-06-08 0001520138-18-000125
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 84,645 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-22 0001520138-16-001265
us-gaap AmortizationOfIntangibleAssets Amortization of Intangible Assets USD 1.58M 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-01 0001520138-22-000131
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 1.58M 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-08-03 0001520138-21-000388
us-gaap Assets Assets USD 32.14M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap AssetsCurrent Assets, Current USD 1.29M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 0 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001096906-23-000699
us-gaap CapitalLeasesContingentRentalPaymentsDue Capital Leases, Contingent Rental Payments Due USD 5,333 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap Cash Cash USD 143,267 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 5,217 2017-01-01 2017-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 112,918 2015-09-30 2015 Q3 10-Q 2015-11-16 0001520138-15-000477
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD 55,937 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001520138-21-000728
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 143,267 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD -3,668 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 50.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 15.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 15.04M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap CommonStockValue Common Stock, Value, Issued USD 368,740 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ContractWithCustomerLiabilityCurrent Contract with Customer, Liability, Current USD 75,200 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ConvertibleDebt Convertible Debt USD 595,638 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap ConvertibleDebtCurrent Convertible Debt, Current USD 100,000 2016-03-07 2016 FY 10-K 2017-04-17 0001520138-17-000143
us-gaap ConvertibleNotesPayable Convertible Notes Payable USD 247,423 2025-06-30 2025 Q2 10-Q 2025-08-13 0001096906-25-001303
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 230,625 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap CostOfGoodsAndServicesSold Cost of Goods and Services Sold USD 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap CostOfGoodsSold Cost of Goods Sold (Deprecated 2018-01-31) USD 1,255 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-22 0001520138-15-000326
us-gaap CostOfRevenue Cost of Revenue USD 1.52M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap DebtConversionConvertedInstrumentAmount1 Debt Conversion, Converted Instrument, Amount USD 86,400 2021-01-01 2021-12-31 2022 FY 10-K 2023-03-31 0001096906-23-000699
us-gaap DebtConversionConvertedInstrumentRate Debt Conversion, Converted Instrument, Rate pure 0.1 2016-03-06 2016-03-07 2016 FY 10-K 2017-04-17 0001520138-17-000143
us-gaap DebtInstrumentAnnualPrincipalPayment Debt Instrument, Annual Principal Payment USD 100,000 2016-11-11 2016 Q3 10-Q 2016-11-22 0001520138-16-001265
us-gaap DebtInstrumentCarryingAmount Long-term Debt, Gross USD 641,876 2019-09-30 2019 Q3 10-Q 2020-06-01 0001520138-20-000252
us-gaap DebtInstrumentInterestRateEffectivePercentage Debt Instrument, Interest Rate, Effective Percentage pure 0.12 2017-06-22 2017 Q3 10-Q 2017-11-15 0001520138-17-000369
us-gaap DebtInstrumentInterestRateIncreaseDecrease Debt Instrument, Interest Rate, Increase (Decrease) pure 0.61 2017-06-01 2017-06-22 2017 Q3 10-Q 2017-11-15 0001520138-17-000369
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 0 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 149,274 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 513,000 2017-12-31 2017 FY 10-K 2018-06-08 0001520138-18-000125
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 574,227 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 574,227 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap DepositsAssets Deposits Assets USD 0 2024-12-31 2024 FY 10-K/A 2025-04-22 0001096906-25-000553
us-gaap DepositsAssetsCurrent Deposits Assets, Current USD 0 2026-06-30 2026 Q2 10-Q 2026-08-14 0001096906-26-001237
us-gaap DepositsAssetsNoncurrent Deposits Assets, Noncurrent USD 38,500 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap DepreciationAndAmortization Depreciation, Depletion and Amortization, Nonproduction USD 1,058 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001520138-15-000477
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 5,100 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-01 0001520138-22-000131
us-gaap DerivativeFairValueOfDerivativeNet Derivative, Fair Value, Net USD 261,734 2025-12-31 2025 FY 10-K 2026-04-09 0001096906-26-000515
us-gaap DerivativeLiabilities Derivative Liability USD 260,815 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 245,523 2016-09-30 2016 Q3 10-Q 2016-11-22 0001520138-16-001265
us-gaap DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold Disposal Group, Including Discontinued Operation, Costs of Goods Sold USD 6,258 2018-01-01 2018-12-31 2019 FY 10-K 2020-08-10 0001520138-20-000365
us-gaap DisposalGroupIncludingDiscontinuedOperationRevenue Disposal Group, Including Discontinued Operation, Revenue USD 0 2018-01-01 2018-12-31 2019 FY 10-K 2020-08-10 0001520138-20-000365
us-gaap DueToRelatedPartiesCurrent Due to Related Parties, Current USD 866 2022-09-30 2022 Q3 10-Q 2022-11-08 0001096906-22-002672
us-gaap DueToRelatedPartiesCurrentAndNoncurrent Due to Related Parties USD 94,040 2022-09-30 2022 Q3 10-Q 2022-11-08 0001096906-22-002672
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares -0.01 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001520138-21-000728
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.34 2016-01-01 2016-12-31 2016 FY 10-K 2017-04-17 0001520138-17-000143
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Net Derivative Asset (Liability), Recurring Basis, Still Held, Unrealized Gain (Loss) USD -91,596 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap FiniteLivedIntangibleAssetsAccumulatedAmortization Finite-Lived Intangible Assets, Accumulated Amortization USD 44,709 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap FiniteLivedIntangibleAssetsNet Finite-Lived Intangible Assets, Net USD 3.73M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap FiniteLivedPatentsGross Finite-Lived Patents, Gross USD 526,647 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ForeignCurrencyTransactionGainLossAfterTax ForeignCurrencyTransactionGainLossAfterTax USD 35,672 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD 32,616 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap GainLossOnDispositionOfAssets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property USD -70,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap GainLossOnDispositionOfAssets1 Gain (Loss) on Disposition of Assets USD 2,664 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-22 0001520138-16-001265
us-gaap GainLossOnSaleOfOtherAssets Gain (Loss) on Disposition of Other Assets USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001096906-24-000706
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD 38,172 2024-01-01 2024-12-31 2024 FY 10-K/A 2025-04-22 0001096906-25-000553
us-gaap GainsLossesOnSalesOfAssets Gain (Loss) on Disposition of Assets for Financial Service Operations USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 4.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap Goodwill Goodwill USD 26.18M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap GoodwillAndIntangibleAssetImpairment Goodwill and Intangible Asset Impairment USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 1.58M 2020-01-01 2020-12-31 2020 FY 10-K/A 2021-08-03 0001520138-21-000388
us-gaap GrossProfit Gross Profit USD 2.78M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ImpairmentOfLongLivedAssetsHeldForUse Impairment of Long-Lived Assets Held-for-use USD 0 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001096906-24-000706
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Noncontrolling Interest USD -348,080 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001520138-15-000477
us-gaap IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -1.98M 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-01 0001520138-22-000131
us-gaap IncomeLossFromContinuingOperationsPerBasicAndDilutedShare Income (Loss) from Continuing Operations, Per Basic and Diluted Share USD/shares -1.21 2018-01-01 2018-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTax Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest USD -6,258 2018-01-01 2018-12-31 2019 FY 10-K 2020-08-10 0001520138-20-000365
us-gaap IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share USD/shares 0 2018-01-01 2018-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD -574,227 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 942,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-06-08 0001520138-18-000125
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD 574,227 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 931,900 2016-01-01 2016-12-31 2016 FY 10-K 2017-04-17 0001520138-17-000143
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 469,816 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncreaseDecreaseInAccountsPayableRelatedParties Increase (Decrease) in Accounts Payable, Related Parties USD 25,526 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001096906-24-000706
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 56,210 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncreaseDecreaseInAccruedInterestReceivableNet Increase (Decrease) in Accrued Interest Receivable, Net USD 0 2024-01-01 2024-12-31 2024 FY 10-K/A 2025-04-22 0001096906-25-000553
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 114,701 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncreaseDecreaseInDeposits Increase (Decrease) in Deposits USD 8,733 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD -91,596 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD 120,515 2023-01-01 2023-12-31 2023 FY 10-K 2024-04-01 0001096906-24-000706
us-gaap IncreaseDecreaseInInterestPayableNet Increase (Decrease) in Interest Payable, Net USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncreaseDecreaseInInventories Increase (Decrease) in Inventories USD -422,315 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap IncreaseDecreaseInNotesReceivables Increase (Decrease) in Notes Receivables USD 391,890 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD -89,102 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-14 0001096906-26-001237
us-gaap IncreaseDecreaseInOtherEmployeeRelatedLiabilities Increase (Decrease) in Other Employee-Related Liabilities USD 25,379 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-16 0001520138-15-000477
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD -5,000 2018-01-01 2018-06-30 2019 Q2 10-Q 2020-05-29 0001520138-20-000248
us-gaap InterestAndOtherIncome Interest and Other Income USD 10,061 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001096906-23-002196
us-gaap InterestExpense Interest Expense USD 125,555 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap InterestExpenseDebt Interest Expense, Debt USD 79,947 2023-01-01 2023-09-30 2023 Q3 10-Q 2023-11-14 0001096906-23-002196
us-gaap InterestExpenseOther Interest Expense, Other USD 907 2016-01-01 2016-09-30 2016 Q3 10-Q 2016-11-22 0001520138-16-001265
us-gaap InterestExpenseRelatedParty Interest Expense, Related Party USD 70,738 2019-01-01 2019-12-31 2019 FY 10-K 2020-08-10 0001520138-20-000365
us-gaap InterestIncomeExpenseNet Interest Income (Expense), Net USD -323,128 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap InterestIncomeOther Interest Income, Other USD 51 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-07-22 0001520138-15-000326
us-gaap InterestPayableCurrent Interest Payable, Current USD 5,523 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap InterestPayableCurrentAndNoncurrent Interest Payable USD 14,214 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap InventoryFinishedGoods Inventory, Finished Goods, Gross USD 466,325 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap InventoryGross Inventory, Gross USD 660,285 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap InventoryNet Inventory, Net USD 572,404 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap InventoryRawMaterials Inventory, Raw Materials, Gross USD 184,814 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap InventoryWorkInProcess Inventory, Work in Process, Gross USD 9,146 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap InventoryWriteDown Inventory Write-down USD 16,378 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 320,025 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap LeaseAndRentalExpense Operating Leases, Rent Expense USD 16,873 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap LeaseCost Lease, Cost USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap LegalFees Legal Fees USD 2,750 2016-10-01 2016-10-26 2016 Q3 10-Q 2016-11-22 0001520138-16-001265
us-gaap LesseeOperatingLeaseDiscountRate Lessee, Operating Lease, Discount Rate pure 0.12 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap Liabilities Liabilities USD 10.93M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 32.14M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 10,000 2017-01-01 2017-12-31 2017 FY 10-K 2018-06-08 0001520138-18-000125
us-gaap LiabilitiesCurrent Liabilities, Current USD 9.17M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 1.77M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap LiabilityForUncertainTaxPositionsCurrent Liability for Uncertainty in Income Taxes, Current USD 0 2016-09-30 2016 Q3 10-Q 2016-11-22 0001520138-16-001265
us-gaap LongTermInvestments Long-term Investments USD 23.54M 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD -418,173 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 59,102 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD 355,403 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD 22.05M 2014-12-19 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD -22,985 2019-01-01 2019-09-30 2019 Q3 10-Q 2020-06-01 0001520138-20-000252
us-gaap NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 Noncash or Part Noncash Acquisition, Intangible Assets Acquired USD 123,415 2018-01-01 2018-09-30 2018 Q3 10-Q 2019-04-25 0001520138-19-000107
us-gaap NoncurrentAssets Long-Lived Assets USD 715,140 2021-12-31 2021 FY 10-K 2022-04-01 0001520138-22-000131
us-gaap NotesPayable Notes Payable USD 1.13M 2020-03-31 2020 Q1 10-Q 2020-08-14 0001520138-20-000385
us-gaap NotesPayableCurrent Notes Payable, Current USD 805,723 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap NotesPayableRelatedPartiesClassifiedCurrent Notes Payable, Related Parties, Current USD 15,000 2016-09-30 2016 Q3 10-Q 2016-11-22 0001520138-16-001265
us-gaap NotesReceivableNet Financing Receivable, after Allowance for Credit Loss USD 391,890 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap NotesReceivableRelatedParties Notes Receivable, Related Parties USD 79,295 2018-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap NotesReceivableRelatedPartiesCurrent Notes Receivable, Related Parties, Current USD 79,295 2018-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap OperatingExpenses Operating Expenses USD 4.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -3.32M 2018-01-01 2018-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 379,496 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 202,593 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 176,903 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2025-12-31 2025 FY 10-K 2026-04-09 0001096906-26-000515
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 188,688 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 19,422 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 6,889 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 82,456 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 79,921 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 0 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 2.88M 2022-12-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap OtherAssets Other Assets USD 30.85M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap OtherAssetsCurrent Other Assets, Current USD 89,102 2026-06-30 2026 Q2 10-Q 2026-08-14 0001096906-26-001237
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 5,291 2015-09-30 2015 Q3 10-Q 2015-11-16 0001520138-15-000477
us-gaap OtherGeneralAndAdministrativeExpense Other General and Administrative Expense USD 239,081 2018-01-01 2018-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -265,860 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap OtherOperatingIncome Other Operating Income USD -97,945 2021-01-01 2021-12-31 2021 FY 10-K 2022-04-01 0001520138-22-000131
us-gaap OtherTaxExpenseBenefit Other Tax Expense (Benefit) USD 3.01M 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap PaymentsToAcquireFurnitureAndFixtures Payments to Acquire Furniture and Fixtures USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap PaymentsToAcquireIntangibleAssets Payments to Acquire Intangible Assets USD 3,000 2017-01-01 2017-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001096906-24-001703
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0.001 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 75.00M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 5,000 2018-06-30 2018 Q2 10-Q 2018-09-11 0001520138-18-000232
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 85,632 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 0 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-14 0001096906-25-001864
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001096906-25-001303
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 15,379 2017-01-01 2017-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap ProceedsFromLoanOriginations1 Proceeds from Loan Originations USD 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001096906-25-001303
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 225,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ProceedsFromRepaymentsOfLinesOfCredit Proceeds from (Repayments of) Lines of Credit USD -65,340 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD 316,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 0 2024-01-01 2024-06-30 2024 Q2 10-Q 2024-08-14 0001096906-24-001703
us-gaap ProceedsFromSalesOfAssetsInvestingActivities Proceeds from Sales of Assets, Investing Activities USD 50,000 2018-01-01 2018-12-31 2019 FY 10-K 2020-08-10 0001520138-20-000365
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 37,500 2016-01-01 2016-12-31 2017 FY 10-K 2018-06-08 0001520138-18-000125
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -1.93M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ReceivableWithImputedInterestDiscount Receivable with Imputed Interest, Discount USD 36,349 2025-12-31 2025 FY 10-K 2026-04-09 0001096906-26-000515
us-gaap RepaymentOfNotesReceivableFromRelatedParties Repayment of Notes Receivable from Related Parties USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 318,095 2022-01-01 2022-12-31 2022 FY 10-K 2023-03-31 0001096906-23-000699
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 397,278 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -22.05M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap Revenues Revenues USD 4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap SalariesWagesAndOfficersCompensation Salary and Wage, Excluding Cost of Good and Service Sold USD 0 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap SalesRevenueNet Revenue, Net (Deprecated 2018-01-31) USD 128,105 2017-01-01 2017-12-31 2017 FY 10-K 2018-06-08 0001520138-18-000125
us-gaap SalesTypeLeaseRevenue Sales-type Lease, Revenue USD 4.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap SellingExpense Selling Expense USD 235,255 2022-01-01 2022-09-30 2022 Q3 10-Q 2022-11-08 0001096906-22-002672
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 0 2023-01-01 2023-03-31 2023 Q1 10-Q 2023-05-15 0001096906-23-001093
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 201 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 3.91 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 4.80M 2015-12-31 2015 FY 10-K 2016-03-30 0001520138-16-000803
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 0.43 2015-12-31 2015 FY 10-K 2016-03-30 0001520138-16-000803
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 7.15M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001520138-16-000803
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 132,680 2024-06-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 0.25 2015-12-31 2015 FY 10-K 2016-03-30 0001520138-16-000803
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 3.70M 2016-01-01 2016-12-31 2016 FY 10-K 2017-04-17 0001520138-17-000143
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0.5 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001520138-16-000803
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0.37 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001520138-16-000803
us-gaap SharePrice Share Price USD/shares 0.021 2020-04-03 2021 FY 10-K 2022-04-01 0001520138-22-000131
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 21.20M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD 238,211 2015-09-30 2015 Q3 10-Q 2015-11-16 0001520138-15-000477
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares -50,000 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-30 0001520138-16-000803
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 1.89M 2020-01-01 2020-12-31 2021 FY 10-K 2022-04-01 0001520138-22-000131
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 388,888 2023-01-01 2023-06-30 2024 Q2 10-Q 2024-08-14 0001096906-24-001703
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 926,008 2018-01-01 2018-12-31 2018 FY 10-K 2020-04-01 0001520138-20-000130
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 329,863 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 329,863 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap TreasuryStockCommonShares Treasury Stock, Common, Shares shares 4,166 2025-12-31 2025 FY 10-K 2026-04-09 0001096906-26-000515
us-gaap TreasuryStockValue Treasury Stock, Value USD 3.89M 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap UnrealizedGainLossOnDerivatives Unrealized Gain (Loss) on Derivatives USD 91,596 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-16 0001096906-26-001782
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 98,809 2015-12-31 2016 FY 10-K 2017-04-17 0001520138-17-000143
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 317.36M 2021-01-01 2021-09-30 2021 Q3 10-Q 2021-11-15 0001520138-21-000728

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →